1. 1051PDComparison of patient populations identified by different PD-L1 assays in head and neck squamous cell carcinoma (HNSCC). (23rd October 2018) Authors: Scott, M; Wildsmith, S; Ratcliffe, M; Al-Masri, H; Scorer, P W; Barker, C; Rebelatto, M C; Walker, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 10OComparison of patient populations identified by different PD-L1 assays in in triple-negative breast cancer (TNBC). (13th May 2019) Authors: Scott, M; Scorer, P; Barker, C; Al-Masri, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 904PImpact of different programmed cell death ligand-1 (PD-L1) expression algorithms on patient selection and durvalumab efficacy in urothelial carcinoma (UC). (23rd October 2018) Authors: Walker, J; Zajac, M; Ye, J; Scott, M; Ratcliffe, M; Scorer, P; Barker, C; Al-Masri, H; Rebelatto, M C; Gupta, A; Mukhopadhay, P; Ferro, S; Powles, T; Williams, J A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗